Role of the human microbiota and probiotics
$970,727ZIAFY2025AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Linked publications & trials
Paper 38518792Paper 36941053Paper 36898551Paper 36646104Paper 35384360Paper 35123653Paper 34065548Paper 33995317Paper 33630954Paper 33522395Paper 32503672Paper 32298967Paper 31866425Paper 30954574Paper 30936487Paper 30117414Paper 29633455Paper 29541068Paper 29507878Paper 28748707Paper 28596942Paper 28377905Paper 28151994Paper 27597849Paper 27160595Paper 26588783Paper 26584249Paper 26579084Paper 25964472Paper 25712972Paper 25701233Paper 25624333Paper 25505739Paper 25214518Paper 25212723Paper 24581690Paper 24514089Paper 24466348Paper 24447915Paper 24222457Paper 24222452Paper 23261595Paper 23165978Paper 22906361Paper 22896791Paper 22830599Paper 22522561Paper 22232686Paper 22095240Paper 21966513Paper 21510745Paper 21173311Paper 21135501Paper 20949069Paper 20660682Paper 20473345Paper 20404927Paper 20402773Paper 20179594Paper 19893740Paper 19710683Paper 19649313Paper 19620329Paper 19609257Paper 18287750Paper 18182108Paper 17890122Paper 17559115Paper 17517597
Abstract
In FY 2025, we continued our efforts to study the molecular underpinnings of staphylococcal colonization on different sites of the human body, such as the skin, nose, and intestine. We are particularly interested in the effects of the human diet on S. aureus intestinal colonization, and as a consequence, S. aureus infection. We are also trying to set up genetic tools to manipulate other members of the human microbiome, such as Cutibacterium acnes, to study their interaction with staphylococci in the human microbiome. Our present focus in this project is to discover and characterize anti-staphylococcal bacteriocins of C. acnes.
View original record on NIH RePORTER →